Maximize Safety in the IV Compounding Process
March 2017 : IV Safety - Vol. 14 No. 3 - Page #4

Q&A with Scott Soefje, PharmD, MBA, BCOP, FCCP

This is part 1 of a two-part series on IV workflow management. Part 1 discusses increasing safety in IV compounding, while part 2, which will appear in a future issue of Pharmacy Purchasing & Products, will address overcoming challenges in IV workflow software implementation.

Pharmacy Purchasing & Products: What are the potential error points in a manual IV preparation process?

Scott Soefje: Sterile IV compounding has become an increasingly complex pursuit for hospital pharmacies. When the United States Pharmacopeia (USP) released the first iteration of Chapter <797> defining sterile IV compounding, many institutions had to significantly redesign their IV compounding processes to ensure compliance. Prior to compounding high-risk drugs in cleanrooms, the components could be set up by the technician and the pharmacist could easily check the product before the mixture was compounded. However, USP <797> introduced important safety measures into the process. The pharmacist must now perform hand hygiene and don personal protective equipment (PPE) to accomplish the same task. While USP <797>-compliant IV compounding is undoubtedly safer, compliance with the chapter has increased compounding complexity.

You've reached the limit of what you can see this month without logging in. Please log in or create a free account.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register: